Current European guidelines for management of cardiovascular disease: Is medical treatment in nearly half a population realistic?

Abstract

Background

Health checks of the general population are widely used to prevent cardiovascular diseases, but are the current clinical guidelines from the European Society of Cardiology (ESC) suitable for screening the general population?

Design

A cross-sectional, population-based study of 978 men and women aged 40–65 years examined in 2010–2011 was used to estimate the proportion of the general Danish population fulfilling the criteria from the clinical guidelines from the ESC on medical treatment and lifestyle intervention to prevent cardiovascular disease.

Methods

The ESC criteria for medical treatment and lifestyle intervention were applied to a general population using information on previous cardiovascular diseases, known diabetes, urinalbumin, smoking, total cholesterol, systolic and diabolic blood pressure, low-density lipoprotein cholesterol and a multifactor risk score (SCORE).

Results

A total of 12.5% fulfilled the criteria for immediate medical treatment to prevent cardiovascular diseases. Furthermore, 30.4% are recommended for medical treatment if an initial lifestyle intervention fails summing to 42.9% eligible for medical treatment. The majority (79%) of persons aged 60–65 years are eligible for medical treatment, while close to half (44.9%) of all persons aged 50–59 years are recommended for medical treatment.

Conclusion

If ESC’s guidelines were followed in Denmark, a conservative estimate shows that medical preventive treatment would involve nearly half the general population aged 40–65 years. The use of these guidelines in screening of the general population can be questioned as realistic and suitable.

Keywords

Cardiovascular disease medical treatment prevention risk chart SCORE

Get full access to this article

View all access options for this article.

References

Lopez

Murray

CJL

Vos

et al.

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 egions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197–2223.

National Institute for Health and Care Excellence. Prevention of cardiovascular disease, 2010. http://www.nice.org.uk/guidance/ph25 (accessed November 2014).

Piepoli

Hoes

Agewall

et al.

European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2016; 23: NP1–NP96.

Krogsbøll

Jørgensen

Larsen

et al.

General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012; 10: CD009009–CD009009.

Jørgensen T, Jacobsen RK, Aadahl M, et al. Effect of screening and lifestyle counselling of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014; 348: g3617. DOI: 10.1136bmj.g3617.

Moss

Sullivan

et al.

Effectiveness of general practice-based health checks: a systematic review and meta-analysis. Br J Gen Pract 2014; 64: 47–53.

Petursson HL, Getz L, Sigurdsson JA, et al. Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population. MBC Fam Pract 2009; 10: 70. DOI: 10.1186/1471-2296-10-70.

Dalton

ARH

Soljak

. The Nationwide Systematic Prevention of Cardiovascular Disease. The UK’s Health Check Programme. J Ambulatory Care Manage 2012; 35: 206–215.

Conroy

Pyorala

Fitzgerald

et al.

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.

10.

Ebrahim

Smith

. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997; 314: 1666–1666.

11.

Osler

Linneberg

Glümer

et al.

The cohorts at the Research Centre for Prevention and Health, formerly ‘The Glostrup Population Studies’. Int J Epidemiol 2011; 40: 602–610.

12.

Bender

Jørgensen

Hansen

et al.

Socioeconomic position and participation in baseline and follow-up visits: the Inter99 Study. Euro J Prev Cardiol 2012; 21: 7–7.

13.

Getz

Sigurdsson

Hetlevik

et al.

Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ 2005; 331: 551–551.

14.

Cederberg

Stancáková

Yaluri

et al.

Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia 2015; 58: 1109–1117.

15.

Lotta

Sharp

Burgess

et al.

Association between LDL-cholesterol lowering genetic variants and risk of rype 2 diabetes. JAMA 2016; 316: 1383–1391.

16.

Jørgensen

. Forebyggelse af livsstilssygdomme.. Hvem skal behandles for at det virker? Månedsskrift for Almen Praksis 2012; 11: 891–897–891–897.

17.

Danish Society of Cardiology, 2014. http://www.cardio.dk/dcs/in-english (accessed 10 November 2014).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.35 MB